Charles Schwab’s NantHealth, Inc NH Stock Holding History

Charles Schwab’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,871	Closed	-$44K	–	3702
2022 Q1	$44K	Hold	3,871	–	–	﹤0.01%	3547
2021 Q4	$62K	Hold	3,871	–	–	﹤0.01%	3492
2021 Q3	$94K	Sell	3,871 -1,028	-21%	-$30.9K	﹤0.01%	3386
2021 Q2	$171K	Hold	4,899	–	–	﹤0.01%	3274
2021 Q1	$236K	Sell	4,899 -796	-14%	-$46.1K	﹤0.01%	3295
2020 Q4	$276K	Hold	5,695	–	–	﹤0.01%	3191
2020 Q3	$200K	Buy	5,695 +1,824	+47%	+$103K	﹤0.01%	3175
2020 Q2	$266K	Buy	+3,871	New	+$154K	﹤0.01%	3096
2019 Q2	–	Sell	-2,033	Closed	-$29K	–	3284
2019 Q1	$29K	Hold	2,033	–	–	﹤0.01%	3185
2018 Q4	$17K	Hold	2,033	–	–	﹤0.01%	3143
2018 Q3	$48K	Hold	2,033	–	–	﹤0.01%	3127
2018 Q2	$101K	Hold	2,033	–	–	﹤0.01%	3100
2018 Q1	$94K	Hold	2,033	–	–	﹤0.01%	3045
2017 Q4	$94K	Sell	2,033 -874	-30%	-$46.3K	﹤0.01%	3036
2017 Q3	$180K	Buy	+2,907	New	+$170K	﹤0.01%	3026
2017 Q2	–	Sell	-987	Closed	-$74K	–	3157
2017 Q1	$74K	Hold	987	–	–	﹤0.01%	3031
2016 Q4	$148K	Buy	+987	New	+$175K	﹤0.01%	3011

Other funds holding NH

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIC

Hartline Investment Corp Winnetka, Illinois $909M AUM 45.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Charles Schwab's NH Position: Q2 2022 in Review

Charles Schwab sold out of NantHealth, Inc (NH) in Q2 2022, closing a stake of 3,871 shares — an estimated $44K sold.

Charles Schwab first reported a position in NH in Q4 2016 and held it in 17 quarters. The position peaked at $276K in Q4 2020. 42 funds tracked by Wall St. Rank hold NH as of Q2 2022.

Charles Schwab reported no remaining NantHealth, Inc position as of Q2 2022 after selling out during the quarter.
Charles Schwab sold 3,871 NantHealth, Inc shares in Q2 2022, an estimated $44K.
Charles Schwab first reported a position in NantHealth, Inc in Q4 2016 and held it in 17 quarters.
Charles Schwab's NantHealth, Inc position peaked at $276K in Q4 2020.
42 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.